Publications by authors named "Christopher D Saffore"

Claim this Profile
R
Real-World Effectiveness and Satisfaction with Risankizumab for the Treatment of Psoriatic Arthritis in Biologic-Naïve Patients: A Population Survey in the United States and Europe.
Jessica A Walsh, Christopher D Saffore, Xiaolan Ye, Manish Patel, Ana Biljan

Rheumatol Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Real-World Comparison of Clinical Effectiveness of Upadacitinib, Tumor Necrosis Factor Inhibitors or Interleukin-17 Inhibitors in Patients with Axial Spondyloarthritis After Switching from an Initial Tumor Necrosis Factor Inhibitor Treatment.
Xenofon Baraliakos, Christopher D Saffore, Xiaolan Ye, Jamie Urbanik, Jayne Stigler

Rheumatol Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Efficacy of Advanced Therapies in the Treatment of Radiographic Axial Spondyloarthritis or Ankylosing Spondylitis as Evaluated by the ASDAS Low Disease Activity Criteria.
Xenofon Baraliakos, Christopher D Saffore, Eric B Collins, Bhumik Parikh, Xiaolan Ye

Rheumatol Ther· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Clinical and Economic Benefit of Advanced Therapies for the Treatment of Active Ankylosing Spondylitis.
Jessica A Walsh, Christopher D Saffore, Eric B Collins, Andrew Ostor

Rheumatol Ther· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of Upadacitinib in Immune-Mediated Inflammatory Diseases: Systematic Literature Review of Indirect and Direct Treatment Comparisons of Randomized Controlled Trials.
Eduardo Mysler, Gerd R Burmester, Christopher D Saffore, John Liu, Lani Wegrzyn

Adv Ther· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and Economic Benefit of Advanced Therapies for the Treatment of Active Ankylosing Spondylitis.
Jessica A Walsh, Christopher D Saffore, Eric B Collins, Andrew Ostor

Rheumatol Ther· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Upadacitinib on Quality of Life and Work Productivity in Active Non-radiographic Axial Spondyloarthritis: Results From Randomized Phase 3 Trial SELECT-AXIS 2.
Uta Kiltz, Mitsumasa Kishimoto, Jessica A Walsh, Percival Sampaio-Barros, Manish Mittal, Christopher D Saffore

Rheumatol Ther· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Upadacitinib on Disease Activity, Pain, Fatigue, Function, Health-Related Quality of Life and Work Productivity for Biologic Refractory Ankylosing Spondylitis.
Victoria Navarro-Compán, Xenofon Baraliakos, Marina Magrey, Andrew Östör, Christopher D Saffore

Rheumatol Ther· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and Economic Benefit of Achieving Disease Control in Psoriatic Arthritis and Ankylosing Spondylitis: A Retrospective Analysis from the OM1 Registry.
Martin J Bergman, Patrick Zueger, Jayeshkumar Patel, Christopher D Saffore, Ia Topuria

Rheumatol Ther· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Geographic Variations in Diagnosis and Treatment of Ankylosing Spondylitis in the United States: A Real-World Study.
Atul Deodhar, Denise Kruzikas, Lili Zhou, Ana Biljan, Christopher D Saffore

Rheumatol Ther· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secondary effects of an opioid-focused academic detailing program on non-opioid controlled substance prescribing in primary care.
Christopher D Saffore, A Simon Pickard, Stephanie Y Crawford, Michael A Fischer, Lisa K Sharp

Subst Abus· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a measure of prescriber satisfaction with academic detailing: the PSAD.
Andrea L Monteiro, Mary Smart, Christopher D Saffore, Todd A Lee, Sarette T Tilton

Drugs Context· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Racial Differences in Prevalence and Treatment for Psoriatic Arthritis and Ankylosing Spondylitis by Insurance Coverage in the USA.
Alexis Ogdie, Wesley Matthias, Richard J Thielen, Daniel Chin, Christopher D Saffore

Rheumatol Ther· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement in Patient-Reported Outcomes in Patients with Psoriatic Arthritis Treated with Upadacitinib Versus Placebo or Adalimumab: Results from SELECT-PsA 1.
Vibeke Strand, Philip J Mease, Enrique R Soriano, Mitsumasa Kishimoto, Carlo Salvarani, Christopher D Saffore

Rheumatol Ther· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-Reported Outcomes in Psoriatic Arthritis Patients with an Inadequate Response to Biologic Disease-Modifying Antirheumatic Drugs: SELECT-PsA 2.
Vibeke Strand, Filip Van den Bosch, Roberto Ranza, Ying-Ying Leung, Edit Drescher, Christopher D Saffore

Rheumatol Ther· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare Resource Use in Patients with Immune-Mediated Conditions Treated with Targeted Immunomodulators During COVID-19 Pandemic: A Retrospective Claims Analysis.
Martin Bergman, Christopher D Saffore, Katherine J Kim, Pankaj A Patel, Vishvas Garg

Adv Ther· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of an Instrument to Assess the Perceived Effectiveness of Academic Detailing.
Mary H Smart, Andrea L Monteiro, Christopher D Saffore, Aleksandrina Ruseva, Todd A Lee

J Contin Educ Health Prof· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practice change intentions after academic detailing align with subsequent opioid prescribing.
Christopher D Saffore, A Simon Pickard, Stephanie Y Crawford, Michael A Fischer, Lisa K Sharp

J Am Pharm Assoc (2003)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Adherence and Persistence Differences Between Adalimumab Citrate-Free and Citrate Formulations for Patients with Immune-Mediated Diseases in the United States.
Martin Bergman, Pankaj Patel, Naijun Chen, Yonghua Jing, Christopher D Saffore

Rheumatol Ther· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of barriers to safe opioid prescribing in primary care: a qualitative analysis of field notes collected through academic detailing.
Christopher D Saffore, Sarette T Tilton, Stephanie Y Crawford, Michael A Fischer, Todd A Lee

Br J Gen Pract· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating the Impact of Food and Drug Administration's Unapproved Drug Initiative on Drug Prices and Sales.
Dolly Sharma, Glen T Schumock, Christopher D Saffore, S Albert Edwards, Surrey M Walton

Ther Innov Regul Sci· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mediation analyses of socioeconomic factors determining racial differences in the treatment of diffuse large B-cell lymphoma in a cohort of older adults.
Jenny S Guadamuz, Katharine Ozenberger, Dima M Qato, Naomi Y Ko, Christopher D Saffore

Medicine (Baltimore)· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of older patients with diffuse large B-cell lymphoma and mild cognitive impairment or dementia.
Christopher D Saffore, Naomi Y Ko, Holly M Holmes, Pritesh R Patel, Karen Sweiss

J Geriatr Oncol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis